ANI Pharmaceuticals (ANIP) has drawn some attention lately as its stock navigates market shifts. This has prompted investors to take a closer look at its recent performance and what could be driving ...

I know how destructive unchecked addiction can be. All the victims of the ongoing opioid crisis do, too. And this is about more than addiction — as when rare but real cases of myocarditis appeared in ...

Now, it’s worth noting Stock Advisor’s total average return is 1,033% — a market-crushing outperformance compared to 193 % ...

Coming up: earnings from AMD, Palantir, top pharmaceutical and tech firms; private-sector employment report; consumer sentiment.

Neither Teva nor the FDA issued guidance on what to do with the recalled tablets. But according to GoodRx, anyone affected by ...

Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

This article first appeared on GuruFocus. Amneal Pharmaceuticals Inc (NASDAQ:AMRX) is set to release its Q3 2025 earnings on Oct 30, 2025. The consensus estimate for Q3 2025 revenue is $0.77 billion, ...

Vertex should earn other important approvals through 2030 that could jolt its stock price. It's developing a treatment called ...

Health Affairs' Jeff Byers welcomes Stacie Dusetzina of Vanderbilt University Medical Center and David Simon of the ...

Aurinia Pharmaceuticals has strong Lupkynis sales, robust pipeline, and financial health drive growth. See why we rate AUPH ...

Once those prices are set, most large government programs that cover prescription drugs pay prices that are tied to ...